RLAY
Relay Therapeutics, Inc.
Stock
$18.96+0.47 (+2.54%)Close Oct 2, 2026
- Revenue, 2025
- $15M
- YoY, 2025
- +53.4%
- 5-year CAGR
- −28.6%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $15M | +53.4% |
| 2024 | $10M | −60.8% |
| 2023 | $26M | +1,749.8% |
| 2022 | $1.4M | −54.4% |
| 2021 | $3.0M | −96.3% |
| 2020 | $83M | — |